Natural history of inherited metabolic storage disorders
Part of Bones, joints & muscles, Brain & nervous system, Genetic & congenital, Hormones & metabolism clinical trials.
This study follows people with certain inherited metabolic conditions (like GM1 or GM2 gangliosidosis, sialidosis, or galactosialidosis) to learn more about how these diseases progress over time. Participating may help researchers understand the conditions better, which could improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of one of these conditions: GM1 or GM2 gangliosidosis, sialidosis, or galactosialidosis.
- Your diagnosis was confirmed by a special lab test (enzyme or genetic testing).
- You can participate regardless of your race, gender, or ethnicity.
- If you are a child, you may be asked for your permission (assent) depending on your age.
- If you are over 18 and cannot give consent, a legally authorized representative (like a parent) can sign for you.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to understand genetic factors in lysosomal storage disorders—rare conditions where the body cannot break down certain substances. Researchers will collect information from patients with these disorders, their family members, and healthy volunteers to learn how these diseases develop and affect people over time.
This study is looking at people with inherited (genetic) neurological conditions, as well as their family members, to better understand these diseases. Participants will receive a thorough evaluation, which may help with diagnosis and research.
This early-stage study tests an IV gene therapy that delivers a working copy of an enzyme gene to help the body make beta-galactosidase in GM1 gangliosidosis. It may help slow or improve disease symptoms and looks closely at safety and how well the treatment works.
This study helps doctors diagnose congenital (from birth) glycosylation disorders, which are inherited conditions that affect how the body builds certain sugar-related proteins. You (or your child) may have clinic visits, blood or other samples, and possibly genetic testing—especially if there are family members with a known or suspected condition.
This study looks at physical and body features in people with creatine transporter deficiency caused by a specific gene change (SLC6A8). It may help doctors better understand the condition and how it shows up, which can improve future care.
This trial studies blood and other measurable signs (biomarkers) that may reflect brain injury after certain inherited metabolic conditions. Results may help doctors better detect and understand brain effects from these illnesses, especially episodes that affect the brain.
Hear when a new Myoclonus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.